Advances in the understanding of acetaminophen toxicity mechanisms: a clinical toxicology perspective

References

• Huynh A, Cairns R, Brown JA, et al. Patterns of poisoning exposure at different ages: the 2015 annual report of the Australian poisons Information centres. Med J Aust. 2018;209(2):74–79. doi: 10.5694/mja17.01063
   PubMed Web of Science ®Google Scholar
• Gummin DD, Mowry JB, Spyker DA, et al. 2018 annual report of the American association of Poison Control Centers’ National Poison data System (NPDS): 36th annual report. Clin Toxicol (Phila). 2019;57(12):1220–1413. doi: 10.1080/15563650.2019.1677022
   PubMed Web of Science ®Google Scholar
• Pathiraja V, Gawarammana I, Buckley N, et al., editors. Paracetamol self-poisoning epidemiology of selected districts of Sri Lanka2019: Asia Pacific Association of Medical Toxicology 18th International Scientific Conference, Putrajaya, Malaysia.
   Google Scholar
• Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Toxicol. 2015;89(2):193–199. doi: 10.1007/s00204-014-1432-2
   PubMed Web of Science ®Google Scholar
• Reuben A, Tillman H, Fontana RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med. 2016;164(11):724–732. doi: 10.7326/M15-2211
   PubMed Web of Science ®Google Scholar
• Prescott L, Illingworth R, Critchley J, et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2(6198):1097–1100. doi: 10.1136/bmj.2.6198.1097
   PubMed Web of Science ®Google Scholar
• Prescott LF. Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Arch Intern Med. 1981;141(3):386–389. doi: 10.1001/archinte.1981.00340030118021
   PubMedGoogle Scholar
• Chiew AL, Gluud C, Brok J, et al. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. 2018;2018(2). (no pagination)(CD003328). doi: 10.1002/14651858.CD003328.pub3
   Google Scholar
• Chiew AL, Isbister GK, Kirby KA, et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol (Phila). 2017;55(10):1055–1065. doi: 10.1080/15563650.2017.1334915
   PubMed Web of Science ®Google Scholar
• Hendrickson RG. What is the most appropriate dose of N-acetylcysteine after massive acetaminophen overdose? Clin Toxicol (Phila). 2019;57(8):686–691. doi: 10.1080/15563650.2019.1579914
   PubMed Web of Science ®Google Scholar
• Link S, Rampon G, Osmon S, et al. Fomepizole as an adjunct to NAC in acetaminophen overdose: a case series. Clin Toxicol (Phila). 2021;59(11):1094.
   Web of Science ®Google Scholar
• Shah KR, Fox C, Geib A-J, et al. Fomepizole as an adjunctive treatment in severe acetaminophen ingestions: a case series. Clin Toxicol (Phila). 2021;59(1):71–72. doi: 10.1080/15563650.2020.1775847
   PubMed Web of Science ®Google Scholar
• Buchan R, Caparrotta T, Eddleston M, et al. Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose - the PP100-01 for overdose of paracetamol (POP) trial: study protocol for a randomised controlled trial 11 Medical and Health sciences 1103 clinical sciences. Trials. 2019;20(1):27.
   PubMedGoogle Scholar
• Mitchell JR, Thorgeirsson SS, Potter WZ, et al. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 1974;16(4):676–684. doi: 10.1002/cpt1974164676
   PubMed Web of Science ®Google Scholar
• Prescott LF. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980;10(Suppl 2):291s–298s. doi: 10.1111/j.1365-2125.1980.tb01812.x
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Liu MY, Kurogi K, et al. Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. J Biochem. 2015;158(6):497–504. doi: 10.1093/jb/mvv062
   PubMed Web of Science ®Google Scholar
• Court MH, Duan SX, von Moltke LL, et al. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther. 2001;299(3):998–1006.
   PubMed Web of Science ®Google Scholar
• Hazai E, Vereczkey L, Monostory K. Reduction of toxic metabolite formation of acetaminophen. Biochem Biophys Res Commun. 2002;291(4):1089–1094. doi: 10.1006/bbrc.2002.6541
   PubMed Web of Science ®Google Scholar
• Manyike PT, Kharasch ED, Kalhorn TF, et al. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther. 2000;67(3):275–282. doi: 10.1067/mcp.2000.104736
   PubMed Web of Science ®Google Scholar
• Corcoran GB, Mitchell JR, Vaishnav YN, et al. Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Mol Pharmacol. 1980;18(3):536–542.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1–2):1–12. doi: 10.1016/j.mam.2008.08.006
   PubMed Web of Science ®Google Scholar
• Jones AL. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Toxicol. 1998;36(4):277–285. doi: 10.3109/15563659809028022
   PubMed Web of Science ®Google Scholar
• Mossanen JC, Tacke F. Acetaminophen-induced acute liver injury in mice. Lab Anim. 2015;49(1_suppl):30–36. doi: 10.1177/0023677215570992
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Xie Y, McGill MR. Acetaminophen-induced liver injury: from animal models to humans. J Clin Transl Hepatol. 2014;2(3):153–161.
   PubMedGoogle Scholar
• McGill MR, Sharpe MR, Williams CD, et al. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest. 2012;122(4):1574–1583. doi: 10.1172/JCI59755
   PubMed Web of Science ®Google Scholar
• Curtis RM, Sivilotti M. A descriptive analysis of AST and ALT rise and fall following acetaminophen overdose. Clin Toxicol (Phila). 2014;52(7):697.
   Web of Science ®Google Scholar
• McGovern AJ, Vitkovitsky IV, DL J, et al. Can AST/ALT ratio indicate recovery after acute paracetamol poisoning? Clin Toxicol (Phila). 2015;53(3):164–167. doi: 10.3109/15563650.2015.1006399
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Jaeschke H. Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology. J Clin Trans Res. 2017;3(Suppl 1):157–169. doi: 10.18053/jctres.03.2017S1.002
   Google Scholar
• Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973;187(1):185–194.
   PubMed Web of Science ®Google Scholar
• Leeming MG, Gamon LF, Wille U, et al. What are the potential sites of protein arylation by N-Acetyl-p-benzoquinone imine (NAPQI)? Chem Res Toxicol. 2015;28(11):2224–2233. doi: 10.1021/acs.chemrestox.5b00373
   PubMed Web of Science ®Google Scholar
• Cohen SD, Khairallah EA. Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev. 1997;29(1–2):59–77. doi: 10.3109/03602539709037573
   PubMed Web of Science ®Google Scholar
• Tirmenstein MA, Nelson SD. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3’-hydroxyacetanilide, in mouse liver. J Biol Chem. 1989;264(17):9814–9819. doi: 10.1016/S0021-9258(18)81731-8
   PubMed Web of Science ®Google Scholar
• Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol (Phila). 2012;50(2):91–98. doi: 10.3109/15563650.2012.659252
   PubMed Web of Science ®Google Scholar
• Rumack BH. Acetaminophen misconceptions. Hepatology. 2004;40(1):10–15. doi: 10.1002/hep.20300
   PubMed Web of Science ®Google Scholar
• Xie Y, McGill MR, Cook SF, et al. Time course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells. Xenobiotica. 2015;45(10):921–929. doi: 10.3109/00498254.2015.1026426
   PubMed Web of Science ®Google Scholar
• Gelotte CK, Auiler JF, Lynch JM, et al. Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharm Therap. 2007;81(6):840–848. doi: 10.1038/sj.clpt.6100121
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Boles JW. The importance of 3‘-phosphoadenosine 5‘-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 1997;11(6):404–418. doi: 10.1096/fasebj.11.6.9194521
   PubMed Web of Science ®Google Scholar
• Mutlib AE, Goosen TC, Bauman JN, et al. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity. Chem Res Toxicol. 2006;19(5):701–709. doi: 10.1021/tx050317i
   PubMed Web of Science ®Google Scholar
• Levy G, Yamada H. Drug biotransformation interactions in Man III: acetaminophen and salicylamide. J Pharm Sci. 1971;60(2):215–221. doi: 10.1002/jps.2600600212
   PubMed Web of Science ®Google Scholar
• Chiew AL, Isbister GK, Stathakis P, et al. Acetaminophen metabolites on presentation following an acute acetaminophen overdose (ATOM-7). Clin Pharmacol Ther. 2023;113(6):1304–1314. doi: 10.1002/cpt.2888
   PubMed Web of Science ®Google Scholar
• Li J, Chiew AL, Isbister GK, et al. Sulfate conjugation may be the key to hepatotoxicity in paracetamol overdose. Br J Clin Pharmacol. 2021;87(5):2392–2396. doi: 10.1111/bcp.14642
   PubMed Web of Science ®Google Scholar
• Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr. 2004;24(1):539–577. doi: 10.1146/annurev.nutr.24.012003.132418
   PubMed Web of Science ®Google Scholar
• Kim HJ, Madhu C, Cho JH, et al. In vivo modification of 3’-phosphoadenosine 5’-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine. Drug Metab Dispos. 1995;23(8):840–845.
   PubMed Web of Science ®Google Scholar
• Levy, G. Sulfate conjugation in drug metabolism: role of inorganic sulfate. Fed Proc. 1986 Jul;45(8): 2235–40. PMID: 3459670 .
   PubMedGoogle Scholar
• Beck L, Silve C. Molecular aspects of renal tubular handling and regulation of inorganic sulfate. Kidney Int. 2001;59(3):835–845. doi: 10.1046/j.1523-1755.2001.059003835.x
   PubMed Web of Science ®Google Scholar
• Gregus Z, Oguro T, Klaassen CD. Nutritionally and chemically induced impairment of sulfate activation and sulfation of xenobiotics in vivo. Chem Biol Interact. 1994;92(1–3):169–177. doi: 10.1016/0009-2797(94)90062-0
   PubMed Web of Science ®Google Scholar
• Galinsky RE, Pharm G, Levy G. Evaluation of activated charcoal-sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate. Clin Toxicol (Phila). 1984;22(1):21–30. doi: 10.3109/00099308409035079
   Web of Science ®Google Scholar
• Vliegenthart A, Kimmitt RA, Seymour JH, et al. Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury. Clin Pharmacol Ther. 2017;101(4):531–540. doi: 10.1002/cpt.541
   PubMed Web of Science ®Google Scholar
• Slattery JT, Levy G. Reduction of acetaminophen toxicity by sodium sulfate in mice. Res Commun Chem Pathol Pharmacol. 1977;18(1):167–170.
   PubMedGoogle Scholar
• Hjelle JJ, Brzeznicka EA, Klaassen CD. Comparison of the effects of sodium sulfate and N-acetylcysteine on the hepatotoxicity of acetaminophen in mice. J Pharmacol Exp Ther. 1986;236(2):526–534.
   PubMed Web of Science ®Google Scholar
• Al-Ali AK, Al-Mustafa ZH, Qaw FS, et al. Paracetamol-induced hepatotoxicity: lack of enhancement of the hepatoprotective effect of N-acetylcysteine by sodium sulphate. Inflammopharmacology. 1998;6(3):235–241. doi: 10.1007/s10787-998-0022-4
   PubMedGoogle Scholar
• Krijgsheld KR, Glazenburg EJ, Scholtens E, et al. The oxidation of L- and D-cysteine to inorganic sulfate and taurine in the rat. Biochim Biophys Acta Gen Subj. 1981;677(1):7–12. doi: 10.1016/0304-4165(81)90139-2
   Google Scholar
• Jaeschke H, McGill MR, Sharpe MR, et al. Mechanisms of acetaminophen hepatotoxicity in humans: involvement of mitochondrial injury and nuclear DNA fragmentation in necrotic cell death. Hepatology. 2011;54(Suppl. 1):519A.
   Google Scholar
• McGill MR, Williams CD, Xie Y, et al. Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol. 2012;264(3):387–394. doi: 10.1016/j.taap.2012.08.015
   PubMed Web of Science ®Google Scholar
• Yan HM, Ramachandran A, Bajt ML, et al. The oxygen tension modulates acetaminophen-induced mitochondrial oxidant stress and cell injury in cultured hepatocytes. Toxicol Sci. 2010;117(2):515–523. doi: 10.1093/toxsci/kfq208
   PubMed Web of Science ®Google Scholar
• Meyers LL, Beierschmitt WP, Khairallah EA, et al. Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. Toxicol Appl Pharmacol. 1988;93(3):378–387. doi: 10.1016/0041-008X(88)90040-3
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Adelusi OB, Akakpo JY, et al. Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls. Acta Pharm Sin B. 2021;11(12):3740–3755. doi: 10.1016/j.apsb.2021.09.023
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Jaeschke H. Acetaminophen toxicity: novel insights into mechanisms and future perspectives. Gene Expr. 2018;18(1):19–30. doi: 10.3727/105221617X15084371374138
   PubMedGoogle Scholar
• Hanawa N, Shinohara M, Saberi B, et al. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem. 2008;283(20):13565–13577. doi: 10.1074/jbc.M708916200
   PubMed Web of Science ®Google Scholar
• Donnelly PJ, Walker RM, Racz WJ. Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity. Arch Toxicol. 1994;68(2):110–118. doi: 10.1007/s002040050043
   PubMed Web of Science ®Google Scholar
• Xie Y, Ramachandran A, Breckenridge DG, et al. Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury. Toxicol Appl Pharmacol. 2015;286(1):1–9. doi: 10.1016/j.taap.2015.03.019
   PubMed Web of Science ®Google Scholar
• Xie Y, McGill MR, Dorko K, et al. Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol Appl Pharmacol. 2014;279(3):266–274. doi: 10.1016/j.taap.2014.05.010
   PubMed Web of Science ®Google Scholar
• Agarwal R, Hennings L, Rafferty TM, et al. Acetaminophen-induced hepatotoxicity and protein nitration in neuronal nitric-oxide synthase knockout mice. J Pharmacol Exp Ther. 2012;340(1):134–142. doi: 10.1124/jpet.111.184192
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Kumagai K, Ito K, et al. Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen. Toxicol Pathol. 2009;37(2):193–200. doi: 10.1177/0192623308329282
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Lebofsky M, Weinman SA, et al. The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 2011;251(3):226–233. doi: 10.1016/j.taap.2011.01.004
   PubMed Web of Science ®Google Scholar
• Knight TR, Ho YS, Farhood A, et al. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther. 2002;303(2):468–475. doi: 10.1124/jpet.102.038968
   PubMed Web of Science ®Google Scholar
• Jaeschke H. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther. 1990;255(3):935–941.
   PubMed Web of Science ®Google Scholar
• Du K, Ramachandran A, Jaeschke H. Oxidative stress during acetaminophen hepatotoxicity: sources, pathophysiological role and therapeutic potential. Redox Biol. 2016;10:148–156. doi: 10.1016/j.redox.2016.10.001
   PubMed Web of Science ®Google Scholar
• Dear JW, Ng ML, Bateman DN, et al. A metabolomic analysis of thiol response for standard and modified N-acetyl cysteine treatment regimens in patients with acetaminophen overdose. Clin Transl Sci. 2021;14(4):1476–1489. doi: 10.1111/cts.13009
   PubMed Web of Science ®Google Scholar
• Battelli MG, Polito L, Bortolotti M, et al. Xanthine oxidoreductase in drug metabolism: beyond a role as a detoxifying enzyme. Curr Med Chem. 2016;23(35):4027–4036. doi: 10.2174/0929867323666160725091915
   PubMed Web of Science ®Google Scholar
• Pavlovic D, Kocic G, Cvetkovic T, et al. A possible role of xanthine oxidase in paracetamol-induced hepatotoxicity. J Hepatol. 1996;25(SUPPL. 1):131.
   Google Scholar
• Whirl-Carrillo M, McDonagh EM, Hebert JM, et al. Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2012;92(4):414–417. doi: 10.1038/clpt.2012.96
   PubMed Web of Science ®Google Scholar
• Heruth DP, Shortt K, Zhang N, et al. Genetic association of single nucleotide polymorphisms with acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther. 2018;367(1):95–100. doi: 10.1124/jpet.118.248583
   PubMed Web of Science ®Google Scholar
• Adjei AA, Gaedigk A, Simon SD, et al. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2008;82(3):155–165. doi: 10.1002/bdra.20535
   PubMedGoogle Scholar
• Zhao L, Pickering G. Paracetamol metabolism and related genetic differences. Drug Metab Rev. 2011;43(1):41–52. doi: 10.3109/03602532.2010.527984
   PubMed Web of Science ®Google Scholar
• Krasniak AE, Knipp GT, Svensson CK, et al. Pharmacogenomics of acetaminophen in pediatric populations: a moving target. Front Genet. 2014;5:314. doi: 10.3389/fgene.2014.00314
   PubMed Web of Science ®Google Scholar
• Critchley J, Nimmo G, Gregson C, et al. Inter‐subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol. 1986;22(6):649–657. doi: 10.1111/j.1365-2125.1986.tb02953.x
   PubMed Web of Science ®Google Scholar
• Court MH, Papageorgiou J. Uncovering genetic and epigenetic mechanisms of human UGT variability that contribute to acetaminophen hepatotoxicity. Drug Metab Rev. 2016;48(Supplement 1):17.
   Google Scholar
• Court MH, Zhu Z, Masse G, et al. Race, gender, and genetic polymorphism contribute to variability in acetaminophen Pharmacokinetics, metabolism, and protein-adduct concentrations in healthy African-American and European-American volunteers. J Pharmacol Exp Ther. 2017;362(3):431–440. doi: 10.1124/jpet.117.242107
   PubMed Web of Science ®Google Scholar
• Court MH, Freytsis M, Wang X, et al. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure. J Pharmacol Exp Ther. 2013;345(2):297–307. doi: 10.1124/jpet.112.202010
   PubMed Web of Science ®Google Scholar
• Monte AA, Arriaga Mackenzie I, Pattee J, et al. Genetic variants associated with ALT elevation from therapeutic acetaminophen. Clin Toxicol (Phila). 2022;60(11):1198–1204. doi: 10.1080/15563650.2022.2117053
   PubMed Web of Science ®Google Scholar
• Marzilawati AR, Ngau YY, Mahadeva S. Low rates of hepatotoxicity among Asian patients with paracetamol overdose: a review of 1024 cases. BMC Pharmacol Toxicol. 2012;13(8). (no pagination). doi: 10.1186/2050-6511-13-8
   PubMedGoogle Scholar
• Green TJ, Sivilotti ML, Langmann C, et al. When do the aminotransferases rise after acute acetaminophen overdose? Clin Toxicol (Phila). 2010;48(8):787–792. doi: 10.3109/15563650.2010.523828
   PubMed Web of Science ®Google Scholar
• Vliegenthart AD, Antoine DJ, Dear JW. Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol. 2015;80(3):351–362. doi: 10.1111/bcp.12699
   PubMed Web of Science ®Google Scholar
• Graudins A. Paracetamol poisoning in adolescents in an Australian setting: not quite adults. Emerg Med Australas. 2015;27(2):139–144. doi: 10.1111/1742-6723.12373
   PubMed Web of Science ®Google Scholar
• Chomchai S, Chomchai C. Predicting acute acetaminophen hepatotoxicity with acetaminophen-aminotransferase multiplication product and the psi parameter. Clin Toxicol (Phila). 2014;52(5):506–511. doi: 10.3109/15563650.2014.917180
   PubMed Web of Science ®Google Scholar
• Sivilotti ML, Green TJ, Langmann C, et al. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clin Toxicol (Phila). 2010;48(8):793–799. doi: 10.3109/15563650.2010.523829
   PubMed Web of Science ®Google Scholar
• Wong A, Sivilotti ML, Dargan PI, et al. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol (Phila). 2015;53(8):807–814. doi: 10.3109/15563650.2015.1066507
   PubMed Web of Science ®Google Scholar
• Wong A, Sivilotti MLA, Graudins A. Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose. Clin Toxicol (Phila). 2017;55(5):346–351. doi: 10.1080/15563650.2017.1290253
   PubMed Web of Science ®Google Scholar
• Schiødt FV, Ott P, Christensen E, et al. The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther. 2002;71(4):221–225. doi: 10.1067/mcp.2002.121857
   PubMed Web of Science ®Google Scholar
• Llewellyn HP, Vaidya VS, Wang Z, et al. Evaluating the sensitivity and specificity of promising circulating biomarkers to diagnose liver injury in humans. Toxicol Sci. 2021;181(1):23–34. doi: 10.1093/toxsci/kfab003
   PubMed Web of Science ®Google Scholar
• Chiew AL, James LP, Isbister GK, et al. Early acetaminophen-protein adducts predict hepatotoxicity following overdose (ATOM-5). J Hepatol. 2020;72(3):450–462. doi: 10.1016/j.jhep.2019.10.030
   PubMed Web of Science ®Google Scholar
• Roberts DW, Lee WM, Hinson JA, et al. An immunoassay to rapidly measure acetaminophen protein adducts accurately identifies patients with acute liver injury or failure. Clin Gastroenterol Hepatol. 2017;15(4):555–62.e3. doi: 10.1016/j.cgh.2016.09.007
   PubMed Web of Science ®Google Scholar
• Davern TJ 2nd, James LP, Hinson JA, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology. 2006;130(3):687–694. doi: 10.1053/j.gastro.2006.01.033
   PubMed Web of Science ®Google Scholar
• James LP, Capparelli EV, Simpson PM, et al. Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther. 2008;84(6):684–690. doi: 10.1038/clpt.2008.190
   PubMed Web of Science ®Google Scholar
• Heard KJ, Green JL, James LP, et al. Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol. 2011;11(20):1–9. doi: 10.1186/1471-230X-11-20
   PubMedGoogle Scholar
• Curry SC, Padilla-Jones A, Ruha AM, et al. The relationship between circulating acetaminophen-protein adduct concentrations and alanine aminotransferase activities in patients with and without acetaminophen overdose and toxicity. J Med Toxicol. 2019;15(3):143–155. doi: 10.1007/s13181-019-00705-2
   PubMed Web of Science ®Google Scholar
• James LP, Letzig L, Simpson PM, et al. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos. 2009;37(8):1779–1784. doi: 10.1124/dmd.108.026195
   PubMed Web of Science ®Google Scholar
• Khandelwal N, James LP, Sanders C, et al. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology. 2011;53(2):567–576. doi: 10.1002/hep.24060
   PubMed Web of Science ®Google Scholar
• James LP, Chiew A, Abdel-Rahman SM, et al. Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations. Eur J Clin Pharmacol. 2013;69(4):851–857. doi: 10.1007/s00228-012-1410-7
   PubMed Web of Science ®Google Scholar
• Wong A, Homer N, Dear JW, et al. Paracetamol metabolite concentrations following low risk overdose treated with an abbreviated 12-h versus 20-h acetylcysteine infusion. Clin Toxicol (Phila). 2019;57(5):312–317. doi: 10.1080/15563650.2018.1517881
   PubMed Web of Science ®Google Scholar
• Vliegenthart AD, Shaffer JM, Clarke JI, et al. Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury. Sci Rep. 2015;5(1):15501. doi: 10.1038/srep15501
   PubMedGoogle Scholar
• Dear JW, Clarke JI, Francis B, et al. Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies. Lancet Gastroenterol Hepatol. 2018;3(2):104–113. doi: 10.1016/S2468-1253(17)30266-2
   PubMed Web of Science ®Google Scholar
• Antoine D, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777–787. doi: 10.1002/hep.26294
   PubMed Web of Science ®Google Scholar
• Church RJ, Kullak‐Ublick GA, Aubrecht J, et al. Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: an international collaborative effort. Hepatology. 2019;69(2):760–773. doi: 10.1002/hep.29802
   PubMed Web of Science ®Google Scholar
• Starkey Lewis PJ, Dear J, Platt V, et al. Circulating microRnas as potential markers of human drug-induced liver injury. Hepatology. 2011;54(5):1767–1776. doi: 10.1002/hep.24538
   PubMed Web of Science ®Google Scholar
• Beger RD, Bhattacharyya S, Yang X, et al. Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol. 2015;89(9):1497–1522. doi: 10.1007/s00204-015-1519-4
   PubMed Web of Science ®Google Scholar
• Dear JW, Antoine DJ, Starkey-Lewis P, et al. Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosis. Br J Clin Pharmacol. 2014;77(5):904–905. doi: 10.1111/bcp.12214
   PubMed Web of Science ®Google Scholar
• Possamai LA, McPhail MJ, Quaglia A, et al. Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure. Crit Care Med. 2013;41(11):2543–2550. doi: 10.1097/CCM.0b013e31829791a2
   PubMed Web of Science ®Google Scholar
• UK Research and Innovation. MICA: point-of-care assessment of drug-induced liver injury (POC-DILI). https://gtr.ukri.org/projects?ref=MR%2FV038303%2F1#/tabOverview Accessed on [26th Jul 2023] 2023
   Google Scholar
• Roth SE, Avigan MI, Bourdet D, et al. Next-generation DILI biomarkers: prioritization of biomarkers for qualification and best practices for biospecimen collection in drug development. Clin Pharmacol Ther. 2020;107(2):333–346. doi: 10.1002/cpt.1571
   PubMed Web of Science ®Google Scholar
• Wong A, Nejad C, Gantier M, et al. MicroRNA from a 12-h versus 20-h acetylcysteine infusion for paracetamol overdose. Hum Exp Toxicol. 2019;38(6):646–654. doi: 10.1177/0960327119833740
   PubMed Web of Science ®Google Scholar
• Kang AM, Padilla-Jones A, Fisher ES, et al. The effect of 4-methylpyrazole on oxidative metabolism of acetaminophen in human volunteers. J Med Toxicol. 2020;16(2):169–176. doi: 10.1007/s13181-019-00740-z
   PubMed Web of Science ®Google Scholar
• Morrison EE, Oatey K, Gallagher B, et al. Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial). EBioMedicine. 2019;46:423–430. doi: 10.1016/j.ebiom.2019.07.013
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, et al. Circulating microRnas, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106(11):4402–4407. doi: 10.1073/pnas.0813371106
   PubMed Web of Science ®Google Scholar
• Faraldi M, Gomarasca M, Sansoni V, et al. Normalization strategies differently affect circulating miRNA profile associated with the training status. Sci Rep. 2019;9(1):1584. doi: 10.1038/s41598-019-38505-x
   PubMedGoogle Scholar
• Yang X, Salminen WF, Shi Q, et al. Potential of extracellular microRnas as biomarkers of acetaminophen toxicity in children. Toxicol Appl Pharmacol. 2015;284(2):180–187. doi: 10.1016/j.taap.2015.02.013
   PubMed Web of Science ®Google Scholar
• Chang J, Nicolas E, Marks D, et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004;1(2):106–113. doi: 10.4161/rna.1.2.1066
   PubMedGoogle Scholar
• Nathwani RA, Pais S, Reynolds TB, et al. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology. 2005;41(2):380–382. doi: 10.1002/hep.20548
   PubMed Web of Science ®Google Scholar
• Bala S, Petrasek J, Mundkur S, et al. Circulating microRnas in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology. 2012;56(5):1946–1957. doi: 10.1002/hep.25873
   PubMed Web of Science ®Google Scholar
• Davern TJ II, James LP, Fontana RJ, et al. 784 serum acetaminophen adducts reliably distinguish acetaminophen toxicity from other causes of acute liver failure. Hepatology. 2003;38(4 Suppl. 1):538A–539A. doi: 10.1016/S0270-9139(03)80826-1
   Web of Science ®Google Scholar
• Prescott LF, Roscoe N, Wright P, et al. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet. 1971;297(7698):519–522. doi: 10.1016/S0140-6736(71)91125-1
   Google Scholar
• Chiew AL, Buckley NA. Acetaminophen poisoning. Crit Care Clin. 2021;37(3):543–561. doi: 10.1016/j.ccc.2021.03.005
   PubMed Web of Science ®Google Scholar
• An JH, Lee HJ, Jung BH. Quantitative analysis of acetaminophen and its six metabolites in rat plasma using liquid chromatography/tandem mass spectrometry. Biomed Chromatogr. 2012;26(12):1596–1604. doi: 10.1002/bmc.2737
   PubMed Web of Science ®Google Scholar
• Chiew A, Day P, Salonikas C, et al. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model. Emerg Med Australas. 2010;22(6):548–555. doi: 10.1111/j.1742-6723.2010.01354.x
   PubMed Web of Science ®Google Scholar
• Olsson B, Johansson M, Gabrielsson J, et al. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol. 1988;34(1):77–82. doi: 10.1007/BF01061422
   PubMed Web of Science ®Google Scholar
• Prescott LF, Donovan JW, Jarvie DR, et al. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol. 1989;37(5):501–506. doi: 10.1007/BF00558131
   PubMed Web of Science ®Google Scholar
• Buckpitt AR, Rollins DE, Mitchell JR. Varying effects of sulfhydryl nucleophiles on acetaminophen oxidation and sulfhydryl adduct formation. Biochem Pharmacol. 1979;28(19):2941–2946. doi: 10.1016/0006-2952(79)90590-2
   PubMed Web of Science ®Google Scholar
• Stravitz RT, Sanyal AJ, Reisch J, et al. Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival. Liver Int. 2013;33(9):1324–1331. doi: 10.1111/liv.12214
   PubMed Web of Science ®Google Scholar
• Harrison PM, Wendon JA, Gimson AES, et al. Improvement by acetylcysteine of Hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991;324(26):1852–1857. doi: 10.1056/NEJM199106273242604
   PubMed Web of Science ®Google Scholar
• Saito C, Zwingmann C, Jaeschke H. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology. 2009;51(1):246–254. doi: 10.1002/hep.23267
   Web of Science ®Google Scholar
• Zafarullah M, Li WQ, Sylvester J, et al. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003;60(1):6–20. doi: 10.1007/s000180300001
   PubMed Web of Science ®Google Scholar
• Rumack BH, Peterson RC, Koch GG, et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981;141(3):380–385. doi: 10.1001/archinte.1981.00340030112020
   PubMedGoogle Scholar
• Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319(24):1557–1562. doi: 10.1056/NEJM198812153192401
   PubMed Web of Science ®Google Scholar
• Harrison PM, Keays R, Bray GP, et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet. 1990;335(8705):1572–1573. doi: 10.1016/0140-6736(90)91388-Q
   PubMed Web of Science ®Google Scholar
• Gunnell D, Hawton K, Murray V, et al. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health. 1997;51(2):175–179. doi: 10.1136/jech.51.2.175
   PubMed Web of Science ®Google Scholar
• Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol. 2002;40(1):3–20. doi: 10.1081/CLT-120002882
   PubMed Web of Science ®Google Scholar
• Bateman DN, Dear JW, Thanacoody HKR. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial (vol 383, 697, 2014). Lancet. 2014;383(9918):696. doi: 10.1016/S0140-6736(13)62062-0
   PubMed Web of Science ®Google Scholar
• Wong A, Graudins A. Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions. Clin Toxicol (Phila). 2016;54(2):115–119. doi: 10.3109/15563650.2015.1115055
   PubMed Web of Science ®Google Scholar
• Chiew AL, Isbister GK, Page CB, et al. Modified release paracetamol overdose: a prospective observational study (ATOM-3). Clin Toxicol (Phila). 2018;56(9):810–819. doi: 10.1080/15563650.2018.1439950
   PubMed Web of Science ®Google Scholar
• Marks D, Dines AM, Lipi M, et al. Clinical outcomes and predictive factors in “massive” paracetamol overdose. Clin Toxicol (Phila). 2016;54(4):423.
   Web of Science ®Google Scholar
• Cairney DG, Beckwith HK, Al-Hourani K, et al. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine. Clin Toxicol (Phila). 2016;54(5):405–410. doi: 10.3109/15563650.2016.1159309
   PubMed Web of Science ®Google Scholar
• Green JL, Heard KJ, Reynolds KM, et al. Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: a systematic review and meta-analysis. West J Emerg Med. 2013;14(3):218–226. doi: 10.5811/westjem.2012.4.6885
   PubMedGoogle Scholar
• Brok J, Buckley N, Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. 2006;2006(2). CD003328. doi: 10.1002/14651858.CD003328.pub2
   Google Scholar
• Beatty L, Green R, Magee K, et al. A systematic review of ethanol and fomepizole use in toxic alcohol ingestions. Emerg Med Int. 2013;2013:638057. doi: 10.1155/2013/638057.
   PubMedGoogle Scholar
• Rasamison R, Besson H, Berleur M-P, et al. Analysis of fomepizole safety based on a 16-year post-marketing experience in France. Clin Toxicol (Phila). 2020;58(7):742–747. doi: 10.1080/15563650.2019.1676899
   PubMed Web of Science ®Google Scholar
• Mullins ME, Yeager LH, Freeman WE. Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review. Clin Toxicol (Phila). 2020;58(12):1284–1296. doi: 10.1080/15563650.2020.1798979
   PubMed Web of Science ®Google Scholar
• Shah KR, Beuhler MC. Fomepizole as an adjunctive treatment in severe acetaminophen toxicity: a case report. Am J Emerg Med. 2019;38(2):410–e5.
   Google Scholar
• Link SL, Rampon G, Osmon S, et al. Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol (Phila). 2022;60(4):472–477. doi: 10.1080/15563650.2021.1996591
   PubMed Web of Science ®Google Scholar
• Pourbagher-Shahri AM, Schimmel J, Shirazi FM, et al. Use of fomepizole (4-methylpyrazole) for acetaminophen poisoning: a scoping review. Toxicol Lett. 2022;355:47–61. doi: 10.1016/j.toxlet.2021.11.005
   PubMed Web of Science ®Google Scholar
• Akakpo JY, Ramachandran A, Duan L, et al. Delayed treatment with 4-methylpyrazole protects against acetaminophen hepatotoxicity in mice by inhibition of c-jun n-terminal kinase. Toxicol Sci. 2019;170(1):57–68. doi: 10.1093/toxsci/kfz077
   PubMed Web of Science ®Google Scholar
• Filip AB, Berg SE, Mullins ME, et al. Fomepizole as an adjunctive therapy for acetaminophen poisoning: cases reported to the toxicology investigators consortium (ToxIC) database 2015-2020. Clin Toxicol (Phila). 2022;60(9):1006–1011. doi: 10.1080/15563650.2022.2070071
   PubMed Web of Science ®Google Scholar
• R D. Denver Health and Hospital Authority. Evaluation of the efficacy of fomepizole in the treatment of acetaminophen overdose. U.S. National Library of Medicines: ClinicalTrials.gov. https://beta.clinicaltrials.gov/study/NCT05517668 Accessed on: 19th Apr 2023
   Google Scholar
• Glimelius B, Manojlovic N, Pfeiffer P, et al. Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT). Acta oncologica. 2018;57(3):393–402. doi: 10.1080/0284186X.2017.1398836
   PubMed Web of Science ®Google Scholar
• Therapeutics E Aladote®- treatment of paracetamol/acetaminophen overdosing. https://www.egetis.com/pipeline/aladote/Accessed on: 2nd May 2023: © 2018-2023 Egetis Therapeutics.
   Google Scholar
• Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026–1029. doi: 10.1136/bmj.303.6809.1026
   PubMed Web of Science ®Google Scholar
• Rampon G, Wartman H, Osmon S, et al. Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series. Toxicol Commun. 2020;4(1):1–4. doi: 10.1080/24734306.2019.1705596
   Google Scholar
• Woolum JA, Hays WB, Patel KH. Use of fomepizole, n-acetylcysteine, and hemodialysis for massive acetaminophen overdose. Am J Emerg Med. 2020;38(3):692. doi: 10.1016/j.ajem.2019.09.026
   Web of Science ®Google Scholar